首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >The pre‐ and post‐authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation
【2h】

The pre‐ and post‐authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation

机译:欧洲药品管理局发布的关于妊娠和哺乳期间使用生物制剂的授权前后数据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effects of biologics on reproduction/lactation are mostly unknown although many patients that receive biologics are women of reproductive age. The first objective of this study was to investigate the publicly available data on pregnancy/lactation before and after marketing authorization in Europe of biologics for the indications of rheumatologic inflammatory autoimmune diseases and inflammatory bowel disease. Secondary objectives included the assessment of the clinical relevance of the provided data and comparison of initial and post‐authorization data.
机译:尽管许多接受生物制剂治疗的患者均为育龄妇女,但对生物制剂对生殖/哺乳的影响尚不清楚。这项研究的第一个目的是调查在风湿性炎症性自身免疫性疾病和炎症性肠病适应症的生物制剂在欧洲上市之前和之后有关妊娠/哺乳的公开数据。次要目标包括评估所提供数据的临床相关性以及比较初始数据和授权后数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号